Nabriva Therapeutics PLC - ADR (NBRV) Stock Declines -10.49% This Week; Should You Buy?

Monday, July 31, 2023 09:41 AM | InvestorsObserver Analysts

Mentioned in this article

Nabriva Therapeutics PLC - ADR (NBRV) Stock Declines -10.49% This Week; Should You Buy?

Nabriva Therapeutics PLC - ADR (NBRV) stock is down -65.96% over the last 12 months. InvestorsObserver’s proprietary ranking system, gives NBRV stock a score of 7 out of a possible 100.

That rank is primarily influenced by a long-term technical score of 8. NBRV's rank also includes a short-term technical score of 15.

NBRV has an Overall Score of 7. Find out what this means to you and get the rest of the rankings on NBRV!

See Full NBRV Report

What's Happening with NBRV Stock Today

Nabriva Therapeutics PLC - ADR (NBRV) stock is higher by 2.84% while the S&P 500 is unchanged 0% as of 9:40 AM on Monday, Jul 31. NBRV has risen $0.04 from the previous closing price of $1.41 on volume of 243,113 shares. Over the past year the S&P 500 is higher by 11.26% while NBRV is down -65.96%. NBRV lost -$18.63 per share in the over the last 12 months. Click Here to get the full Stock Report for Nabriva Therapeutics PLC - ADR stock.